Joel Greenblatt's NEO Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 50,818 shares of NeoGenomics, Inc. (NEO) worth $933,018, representing 0.00% of the portfolio. First purchased in 2016-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in NEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 50,818 shares. Largest reduction occurred in Q3 2023, reducing 32,092 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's NeoGenomics (NEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly NeoGenomics (NEO) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +50,818 | New Buy | 50,818 | $18.36 |
| Q1 2024 | -12,765 | Sold Out | 0 | $0.00 |
| Q4 2023 | +1,690 | Add 15.26% | 12,765 | $16.18 |
| Q3 2023 | -32,092 | Reduce 74.34% | 11,075 | $12.30 |
| Q2 2023 | +32,171 | Add 292.57% | 43,167 | $16.07 |
| Q1 2023 | +10,996 | New Buy | 10,996 | $17.41 |
| Q1 2019 | -23,378 | Sold Out | 0 | $0.00 |
| Q4 2018 | +23,378 | New Buy | 23,378 | $12.62 |
| Q3 2018 | -11,024 | Sold Out | 0 | $0.00 |
| Q2 2018 | +11,024 | New Buy | 11,024 | $13.15 |
| Q2 2017 | -14,920 | Sold Out | 0 | $0.00 |
| Q1 2017 | -4,782 | Reduce 24.27% | 14,920 | $7.91 |
| Q4 2016 | -4,701 | Reduce 19.26% | 19,702 | $8.58 |
| Q3 2016 | -1,351 | Reduce 5.25% | 24,403 | $8.24 |
| Q2 2016 | +25,754 | New Buy | 25,754 | $8.04 |
Joel Greenblatt's NeoGenomics Investment FAQs
Joel Greenblatt first purchased NeoGenomics, Inc. (NEO) in Q2 2016, acquiring 25,754 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held NeoGenomics, Inc. (NEO) for 15 quarters since Q2 2016.
Joel Greenblatt's largest addition to NeoGenomics, Inc. (NEO) was in Q3 2026, adding 50,818 shares worth $933,018.
According to the latest 13F filing for Q3 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 50,818 shares of NeoGenomics, Inc. (NEO), valued at approximately $933,018.
As of the Q3 2026 filing, NeoGenomics, Inc. (NEO) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in NeoGenomics, Inc. (NEO) was 50,818 shares, as reported at the end of Q3 2026.